Cornerstone Wealth Group’s Clearmind Medicine CMND Stock Holding History

Cornerstone Wealth Group’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50	Closed	-$18K	–	353
2025 Q2	$18K	Hold	50	–	–	﹤0.01%	324
2025 Q1	$20.7K	Hold	50	–	–	﹤0.01%	288
2024 Q4	$27.6K	Hold	50	–	–	﹤0.01%	273
2024 Q3	$24.4K	Hold	50	–	–	﹤0.01%	265
2024 Q2	$33.6K	Buy	+50	New	+$24.2K	﹤0.01%	248

Other funds holding CMND

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Cornerstone Wealth Group's CMND Position: Q3 2025 in Review

Cornerstone Wealth Group sold out of Clearmind Medicine (CMND) in Q3 2025, closing a stake of 50 shares — an estimated $18K sold.

Cornerstone Wealth Group first reported a position in CMND in Q2 2024 and held it in 5 quarters. The position peaked at $33.6K in Q2 2024. 7 funds tracked by Wall St. Rank hold CMND as of Q3 2025.

Cornerstone Wealth Group reported no remaining Clearmind Medicine position as of Q3 2025 after selling out during the quarter.
Cornerstone Wealth Group sold 50 Clearmind Medicine shares in Q3 2025, an estimated $18K.
Cornerstone Wealth Group first reported a position in Clearmind Medicine in Q2 2024 and held it in 5 quarters.
Cornerstone Wealth Group's Clearmind Medicine position peaked at $33.6K in Q2 2024.
7 funds tracked by Wall St. Rank held Clearmind Medicine as of Q3 2025.

Based on Cornerstone Wealth Group's 13F filing for Q3 2025, filed 30 Oct 2025.